Video

REVIEW UroToday

Practical Aspects of Operationalizing Lutetium-177 (177Lu)–PSMA-617 in the Urology Clinic VL

Search

Operationalizing Lutetium-177-PSMA Programs - William Oresick Details In a comprehensive discussion with Phillip Koo, Bill Oresick outlines the process of integrating a Lutetium-177-PSMA program into a large urology group practice. Mr. Oresick emphasizes the importance of thorough research and cost analysis before launching any Radioligand Therapy (RLT) program. He highlights the need for a qualified physicist and a nuclear medicine technologist to ensure safety and...
How One Urology Clinic Successfully Sets Up a Hot Lab for Radioligand Therapy Program - William Oresick Details Specialized laboratories, which are called hot laboratories, are specially designed and equipped to handle radioactive materials of high activity, including plutonium and transplutonium elements. The handling of lutetium presents special radiation protection and safety because of its high specific activity and radiotoxicity. Therefore, the planning, design, construction, and operation of hot labor...
Clinical Considerations for Patient Selection for Lutetium-177 PSMA- Gordon Brown Details In a detailed conversation with Phillip Koo, Gordon Brown delves into the clinical considerations of integrating PLUVICTO into urology practices. Dr. Brown explains the role of Summit Health's navigation team in identifying and monitoring patients for advanced prostate cancer therapies. He discusses the criteria for patient selection, emphasizing the importance of PSMA PET imaging, which is outsou...
Patient Navigation in the Advanced Prostate Clinic for Lutetium-177 PSMA Therapy - Christina Fareri Details In this discussion, Phillip Koo converses with Chrissy Fareri focusing on the patient journey in a Lutetium-177 PSMA program. Dr. Fareri outlines the nurse navigator's role in guiding patients through a nine-month treatment period, including lab reviews and side effect management. She emphasizes the importance of hydration and provides insights into the personalized service offered at Summit Healt...
Lutetium-177 PSMA in Urology: Radiation Safety and Authorized User Considerations - Glen Gejerman Details In this discussion, Phillip Koo welcomes Glen Gejerman to explore the integration of Lutetium-177 PSMA into large urology group practices. The conversation initially centers on the concept of an "authorized user," emphasizing its importance in radiation oncology and outlining the qualifications needed. Dr. Gejerman advises starting with a Radiation Safety Officer when identifying an authorized use...
Summit Health's Approach to Incorporating Lutetium-177 PSMA in the Multidisciplinary Setting - Gordon Brown & Glen Gejerman Details Phillip Koo engages with Gordon Brown and Glen Gejerman to explore the multidisciplinary aspects of integrating a Lutetium-177 PSMA program into a large urology practice. Dr. Brown outlines the meticulous patient identification and evaluation process, emphasizing the role of PSMA scans and FDA indications for Lu-177 therapy. Dr. Gejerman elaborates on the subsequent steps, including patient educat...